AbbVie deal may conclude a tumultuous 4 years for Botox-maker Allergan

By

AbbVie deal may conclude a tumultuous 4 years for Botox-maker Allergan

AbbVie’s deal to buy Allergan for about $63 billion is a "nice exit from a tough situation," RBC Capital Markets analyst Randall Stanicky says.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.